Immune response and protective efficacy of the SARS-CoV-2 recombinant spike protein vaccine S-268019-b in mice

Vaccines that efficiently target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent for coronavirus disease (COVID-19), are the best means for controlling viral spread. This study evaluated the efficacy of the COVID-19 vaccine S-268019-b, which comprises the recombin...

Descripción completa

Detalles Bibliográficos
Autores principales: Homma, Tomoyuki, Nagata, Noriyo, Hashimoto, Masayuki, Iwata-Yoshikawa, Naoko, Seki, Naomi M., Shiwa-Sudo, Nozomi, Ainai, Akira, Dohi, Keiji, Nikaido, Eiji, Mukai, Akiko, Ukai, Yuuta, Nakagawa, Takayuki, Shimo, Yusuke, Maeda, Hiroki, Shirai, Seiki, Aoki, Miwa, Sonoyama, Takuhiro, Sato, Mamoru, Fumoto, Masataka, Nagira, Morio, Nakata, Fumihisa, Hashiguchi, Takao, Suzuki, Tadaki, Omoto, Shinya, Hasegawa, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718471/
https://www.ncbi.nlm.nih.gov/pubmed/36460696
http://dx.doi.org/10.1038/s41598-022-25418-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9718471/
https://www.ncbi.nlm.nih.gov/pubmed/36460696
http://dx.doi.org/10.1038/s41598-022-25418-5

Ejemplares similares